A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : SUDs / substance use disorders

[Related PubMed/MEDLINE]
Total Number of Papers: 1506
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   SUDs  (>> Co-occurring Abbreviation)
Long Form:   substance use disorders
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
1  2023 A Qualitative Study of Emergency Physicians' and Nurses' Experiences Caring for Patients With Psychiatric Conditions and/or Substance Use Disorders. EDs
2  2023 A relational agent for treating substance use in adults: Protocol for a randomized controlled trial with a psychoeducational comparator. EOT, W-SUDs
3  2023 Adverse childhood experiences are associated with increased overdose risk in predominately Latinx adults seeking treatment for substance use disorders. ACEs, SUD
4  2023 Association of Medicaid expansion and 1115 waivers for substance use disorders with hospital provision of opioid use disorder services: a cross sectional study. OR, OUD
5  2023 Changes in Substance Use Treatment Providers' Delivery of the 5A's for Non-Cigarette Tobacco Use in the Context of a Comprehensive Tobacco-Free Workplace Program Implementation. SUTCs, TFWP, TUA, TUD
6  2023 Dementia, Substance Misuse, and Social Determinants of Health: American Indian and Alaska Native Peoples' Prevention, Service, and Care. ADRD, AI/AN, SDH
7  2023 Demographic trends associated with substance use disorder and risk for adverse obstetric outcomes with cannabis and opioid use disorders. AAPC, aRRs, CIs
8  2023 Faculty, staff, and student perceptions of substance use disorder stigma in health profession training programs: a quantitative study. ---
9  2023 Heterogeneity In Women's Trauma Histories: Impact On Substance Use Disorder Severity. ---
10  2023 High frequency deep brain stimulation can mitigate the acute effects of cocaine administration on tonic dopamine levels in the rat nucleus accumbens. DBS, HFS, M-CSWV, NAc, NAcc, VTA
11  2023 High Risk of Substance Use Disorder-Related Outcomes in Veterans Released from Correctional Facilities in Mid to Late Life. aHR, CI, ED/IPH, VA
12  2023 Hospitalization Associated With Comorbid Psychiatric and Substance Use Disorders Among Adults With COVID-19 Treated in US Emergency Departments From April 2020 to August 2021. ADHD, ED, PDs, PTSD
13  2023 Individual factors predict substance use treatment course patterns among patients in community-based substance use disorder treatment. ---
14  2023 Machine learning with neuroimaging biomarkers: Application in the diagnosis and prediction of drug addiction. ML
15  2023 Medical Costs of Substance Use Disorders in the US Employer-Sponsored Insurance Population. ESI
16  2023 Mood Variability, Craving, and Substance Use Disorders: From Intrinsic Brain Network Connectivity to Daily Life Experience. ---
17  2023 Neural circuits controlling choice behavior in opioid addiction. OUD
18  2023 Patient Preferences for Mobile Health Applications to Support Recovery. A-CHESS
19  2023 Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder. BDNF, NfL, PRISM
20  2023 Repetitive transcranial magnetic stimulation (rTMS) is associated with increased abstinence in substance use disorders and comorbid depression. BSCS, CGI-S, MDD, rTMS
21  2023 Sex differences in neural responses to stress and drug cues predicts future drug use in individuals with substance use disorder. fMRI, vmPFC
22  2023 Substance Use Disorders Are Prevalent in Adults With Congenital Heart Disease and Are Associated With Increased Healthcare Use. APAC, CHD
23  2023 Synchronised transcranial magnetic stimulation for substance use-disordered Veterans: protocol for the pilot sham-controlled acceptability trial. sTMS
24  2023 Telehealth interventions for substance use disorders in low- and- middle income countries: A scoping review. LMICs
25  2023 Testing and Case Rates of Gonorrhea, Chlamydia, Syphilis, and HIV among People with Substance Use Disorders in the Veterans Health Administration. STI
26  2023 The Associations between Remission Status, Discounting Rates, and Recovery from Substance Use Disorders. DD, IQRR, PD
27  2023 The importance of translationally evaluating steroid hormone contributions to substance use. Pg
28  2023 The prevalence of substance use disorders and associated patterns among patients admitted to a psychiatric hospital in Botswana. ---
29  2022 "I Grew Up Amidst Alcohol and Drugs:" a Qualitative Study on the Lived Experiences of Parental Substance Use Among Adults Who Developed Substance Use Disorders Themselves. PSU
30  2022 "It Just Depends on Their Stability": A Qualitative Examination of Patient Factors Influencing Providers' Contraceptive Counseling Approaches for Persons With Substance Use Disorders. ---
31  2022 "They didn't have any idea what drugs were": Pathways to substance use disorders among ultraorthodox Jewish males. ---
32  2022 A comparison of cognitive behavioral therapy for insomnia to standard of care in an outpatient substance use disorder clinic embedded within a therapeutic community: a RE-AIM framework evaluation. CBT-I, gCBT-I, ISI, SOC
33  2022 A methodological checklist for fMRI drug cue reactivity studies: development and expert consensus. ENIGMA, FDCR, fMRI
34  2022 A national profile of substance use disorder among Medicaid enrollees on the autism spectrum or with intellectual disability. ASD, ID
35  2022 A Pilot Study Examining Access to and Satisfaction with Maternal Mental Health and Substance Use Disorder Treatment via Telemedicine. MH
36  2022 A preliminary investigation of the role of intraindividual sleep variability in substance use treatment outcomes. SE, SM, TST
37  2022 A randomized clinical trial evaluating the impact of counselor training and patient feedback on substance use disorder patients' sexual risk behavior. PFR, USO
38  2022 A Review of Immunotherapeutic Approaches for Substance Use Disorders: Current Status and Future Prospects. ---
39  2022 A scoping review of electroencephalographic (EEG) markers for tracking neurophysiological changes and predicting outcomes in substance use disorder treatment. EEG, LPP
40  2022 A Student Walks into Class … Vignettes to Identify Substance Use Disorder Models of Illness among College Students. ---
41  2022 A systematic literature review of clinical trials and therapeutic applications of ibogaine. ---
42  2022 A systematic review of post-release programs for women exiting prison with substance-use disorders: assessing current programs and weighing the evidence. ROBINS-I
43  2022 A systematic review of qualitative research on substance use among refugees. ---
44  2022 Abnormal resting-state functional connectome in methamphetamine-dependent patients and its application in machine-learning-based classification. AUC, E glob, LASSO, Lp, MA, OFC, rsFC, SVM
45  2022 Adult Attention-Deficit Hyperactivity Disorder/Substance Use Disorder Dual Disorder Patients: A Dual Disorder Unit Point of View. ADHD
46  2022 An Overview of Mindfulness-Oriented Addiction and Pain Recovery. ---
47  2022 Are Borderline Personality Disorder Features Differentially Related to Pre-Incarceration Alcohol, Cannabis, Cocaine, and Opioid Dependence Among People Recently Incarcerated in Jail? BPD
48  2022 Are perinatal measures associated with adolescent mental health? A retrospective exploration with original data from psychiatric cohorts. IQ, YSR
49  2022 Assessing Childhood Maltreatment Exposure in Patients Without and With a Diagnosis of Substance Use Disorder. CM, CTQ, ROC
50  2022 Association of Drug Cues and Craving With Drug Use and Relapse: A Systematic Review and Meta-analysis. ORs, PRISMA
51  2022 Association of Pharmacological Treatments and Hospitalization and Death in Individuals With Amphetamine Use Disorders in a Swedish Nationwide Cohort of 13 965 Patients. aHR
52  2022 Association of polysubstance use disorder with treatment quality among Medicaid beneficiaries with opioid use disorder. OUD
53  2022 Association of Prepregnancy Substance Use and Substance Use Disorders with Pregnancy Timing and Intention. aPRs, CIs
54  2022 Associations Between Adverse Childhood Experiences and Tobacco, Alcohol, and Drug Use Among Individuals with Serious Mental Illnesses in Public-Sector Treatment Settings. ACEs, SMI
55  2022 Attitudes of health professionals towards people with substance use disorders in Brazil, controlling for the effects of social desirability. OMS-HC, PHC, SD
56  2022 Barriers to enrolling in voluntary treatment programs in Malaysia: a study of women who use methamphetamine (WWUM). CDDC, VTCs, WWUM
57  2022 Barriers to treatment of alcohol and tobacco use disorders in industrial workers. ---
58  2022 Behavioral activation for depression delivered by drug and alcohol treatment workers: A pilot randomized controlled trial. BA, CDAT, PDA, RCT
59  2022 Behavioral Addictive Disorders in Children and Adolescents. BADs
60  2022 Behavioral Profiles of Adolescent Alcohol-Preferring/Non-preferring (P/NP) and High/Low Alcohol-Drinking (HAD/LAD) Rats Are Dependent on Line but Not Sex. MCSF, P/NP
61  2022 Being at work improves stress, craving, and mood for people with opioid use disorder: Ecological momentary assessment during a randomized trial of experimental employment in a contingency-management-based therapeutic workplace. ---
62  2022 Biopsychosocial factors associated with complications in patients with frostbite. ---
63  2022 Building a strong foundation from the ground up: the impact of a medical student substance use disorder organization on curriculum and community. DvA
64  2022 Can initial experiences with drugs predict future drug abuse risks? AUD, CUD
65  2022 Cannabidiol in the context of substance use disorder treatment: A systematic review. CBD
66  2022 Characterizing Clinical Heterogeneity in a Large Inpatient Addiction Treatment Sample: Confirmatory Latent Profile Analysis and Differential Levels of Craving and Impulsivity. CLPA
67  2022 Characterizing Help-Seeking Searches for Substance Use Treatment From Google Trends and Assessing Their Use for Infoveillance: Longitudinal Descriptive and Validation Statistical Analysis. ---
68  2022 Characterizing problematic internet use in a sample of heavy drinking emerging adults. PIU, QoL
69  2022 Childhood trauma and food addiction: The role of emotion regulation difficulties and gender differences. ---
70  2022 Chronic pain and substance use disorders among older sexual minority men living with HIV: Implications for HIV disease management across the HIV care continuum. SMM
71  2022 Clinical, environmental, and genetic risk factors for substance use disorders: characterizing combined effects across multiple cohorts. CERI, PGS
72  2022 Cocaine use disorder criteria in a clinical sample: an analysis using Item Response Theory, factor analysis, and network analysis. CUD, IRT
73  2022 Collaborative approach to harm reduction by managed care pharmacy team for populations with substance use disorder. MOUD
74  2022 Community-based residential treatment for alcohol and substance use problems: A realist review. CMO
75  2022 Comparative effectiveness of trauma-focused and non-trauma-focused psychotherapy for PTSD among veterans with comorbid substance use disorders: Protocol & rationale for a randomized clinical trial. NTFT, PCT, PTSD, TFT
76  2022 Comparison of Substance Use Disorder Diagnosis Rates From Electronic Health Record Data With Substance Use Disorder Prevalence Rates Reported in Surveys Across Sociodemographic Groups in the Veterans Health Administration. AUD, DUD, EHR, VHA
77  2022 Confirmatory factor analysis of 20-item toronto alexithymia scale in spanish patients with substance use disorder. ---
78  2022 Coping motives mediate the relationship between PTSD and MDMA use in adolescents with substance use disorders. PTSD
79  2022 Coronavirus Disease 2019 and the Impact on Substance Use Disorder Treatments. COVID-19
80  2022 Corticostriatal contributions to dysregulated motivated behaviors in stress, depression, and substance use disorders. ---
81  2022 Cost and Cost Savings of Navigation Services to Avoid Rehospitalization for a Comorbid Substance Use Disorder Population. ED, NavSTAR
82  2022 COVID 19-impact on substance use treatment utilization and provision in South Africa. COVID-19, SACENDU
83  2022 COVID-19 Lockdown and Consumption Patterns among Substance Use Disorder Outpatients: A Multicentre Study. ---
84  2022 Cultural adaptation and psychometric properties of the Substance Abuse Self-Stigma Scale among Latinos with Substance Use Disorders: An effective screening tool for correctional and community settings. SASSS
85  2022 Cultural Adaptation and Validation of the Urdu Version of the Cognitive Emotion Regulation Questionnaire (CERQ) in Male Patients With Substance Use Disorders (SUDs) in Pakistan. CERQ, RSES
86  2022 Current Trends and Perspectives in the Immune Therapy for Substance Use Disorders. EMA, FDA
87  2022 Delivery Outcomes Among Pregnant Women With Comorbid Psychiatric and Substance Use Disorders Receiving Comprehensive Treatment. ---
88  2022 Description and outcomes of patients with substance use disorder with serious bacterial infections who had a multidisciplinary care conference. ---
89  2022 Diagnostic accuracy of Achenbach scales in detecting youths' substance use disorders. CBCL, DSM, K-SADS-PL, ROC, YSR
90  2022 Diagnostic accuracy of the Child and Adolescent Symptom Inventory (CASI-4R) substance use subscale in detecting substance use disorders in youth. AUC, AYA, CASI, ROC, SU
91  2022 Differences in alcohol and cannabis use amongst substance use disorder patients with and without comorbid attention-deficit/hyperactivity disorder. ADHD, SANCA
92  2022 Digital Treatment Paths for Substance Use Disorders (SUDs). ---
93  2022 Direct Medical Cost of Treating Substance Use Disorders in Two Tertiary Hospitals in South-West, Nigeria: A Cross-Sectional Study. ---
94  2022 Disparities in smoking prevalence and associations with mental health and substance use disorders in underserved communities across the United States. aOR, CI
95  2022 Distinct brain structural abnormalities in attention-deficit/hyperactivity disorder and substance use disorders: A comparative meta-analysis. ADHD, GMV, VBM
96  2022 Does Effectiveness of a Brief Substance Use Treatment Depend on PTSD? An Evaluation of Motivational Enhancement Therapy for Active-Duty Army Personnel. MET, PTSD
97  2022 Does the Augmentation of Trauma Informed Hatha Yoga Increase the Effect of Dialectical Behavior Therapy for Substance Use Disorders on Psychopathological Strain of Patients with Borderline Personality Disorder and Comorbid Substance Use Disorder? Results of a Quasi-Experimental Study. BDI, BPD, DBT-S, PSS
98  2022 Dose titration with the glucagon-like peptide-1 agonist, liraglutide, reduces cue- and drug-induced heroin seeking in high drug-taking rats. GLP-1RAs, MAT, OUD
99  2022 Doula engagement and maternal opioid use disorder (OUD): Experiences of women in OUD recovery during the perinatal period. OUD
100  2022 Drug versus non-drug behaviors: A dual-reward model of sex differences and neurobiological mechanisms in rats. ---